Chemotherapy and target therapy as neo-adjuvant approach for initially unresectable colorectal liver metastases
Although surgery is the most effective treatment for liver metastases in colorectal cancer patients, only 15-20% of these patients are suitable for a radical surgical approach, and metastases recurrence may occur at follow up. In the last decade, the use of pre-operative chemotherapy in combination...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Book |
| Published: |
Frontiers Media S.A.,
2012-06-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000 am a22000003u 4500 | ||
|---|---|---|---|
| 001 | doaj_efe16c816a344f4991f3dba7ffec772a | ||
| 042 | |a dc | ||
| 100 | 1 | 0 | |a Luigi Rossi |e author |
| 700 | 1 | 0 | |a Angelo Zullo |e author |
| 700 | 1 | 0 | |a Federica Zoratto |e author |
| 700 | 1 | 0 | |a Anselmo Papa |e author |
| 700 | 1 | 0 | |a Martina Strudel |e author |
| 700 | 1 | 0 | |a Maria Colonna |e author |
| 700 | 1 | 0 | |a Silverio Tomao |e author |
| 245 | 0 | 0 | |a Chemotherapy and target therapy as neo-adjuvant approach for initially unresectable colorectal liver metastases |
| 260 | |b Frontiers Media S.A., |c 2012-06-01T00:00:00Z. | ||
| 500 | |a 10.4081/oncol.2012.e6 | ||
| 500 | |a 1970-5557 | ||
| 500 | |a 1970-5565 | ||
| 520 | |a Although surgery is the most effective treatment for liver metastases in colorectal cancer patients, only 15-20% of these patients are suitable for a radical surgical approach, and metastases recurrence may occur at follow up. In the last decade, the use of pre-operative chemotherapy in combination with new biological drugs has been introduced. We reviewed data of neo-adjuvant chemotherapy strategies aimed at increasing the resection rate of liver metastases in colorectal cancer patients who were initially considered unresectable. | ||
| 546 | |a EN | ||
| 690 | |a liver metastasis | ||
| 690 | |a colorectal cancer | ||
| 690 | |a chemotherapy | ||
| 690 | |a neo-adjuvant chemotherapy | ||
| 690 | |a biological therapy | ||
| 690 | |a bevacizumab | ||
| 690 | |a Other systems of medicine | ||
| 690 | |a RZ201-999 | ||
| 690 | |a Internal medicine | ||
| 690 | |a RC31-1245 | ||
| 655 | 7 | |a article |2 local | |
| 786 | 0 | |n Oncology Reviews, Vol 6, Iss 1 (2012) | |
| 787 | 0 | |n http://www.oncologyreviews.org/index.php/or/article/view/179 | |
| 787 | 0 | |n https://doaj.org/toc/1970-5557 | |
| 787 | 0 | |n https://doaj.org/toc/1970-5565 | |
| 856 | 4 | 1 | |u https://doaj.org/article/efe16c816a344f4991f3dba7ffec772a |z Connect to this object online. |